Immunovative Therapies, Ltd.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 27228
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 22145
 
  
 
C07K PEPTIDES 4132
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 2238
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
  
 
B65B MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING 163
 
  
 
G05B CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS 1100
 
  
 
G06F ELECTRIC DIGITAL DATA PROCESSING 1446
 
  
 
G07F COIN- FREED OR LIKE APPARATUS 157

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0360,909 Method for allogeneic cell therapyAug 30, 17Dec 21, 17[A61K, C12N]
2017/0290,857 Kit for increasing Th1 cellsJun 22, 17Oct 12, 17[A61K, C12N]
2017/0281,743 Th1 vaccination priming for active immunotherapyJun 22, 17Oct 05, 17[A61K]
2016/0361,404 Methods and compositions for inhibition of Treg cellsAug 24, 16Dec 15, 16[A61K]
2016/0243,231 Ablative ImmunotherapyMar 22, 16Aug 25, 16[A61K, A61B]
2016/0206,718 Compositions for Liquidation of TumorsMar 29, 16Jul 21, 16[A61K]
2016/0144,010 Ablative immunotherapyJan 21, 16May 26, 16[A61K]
2016/0136,270 Ablative immunotherapyJan 21, 16May 19, 16[A61K]
2014/0178,334 Methods and compositions for liquidation of tumorsFeb 28, 14Jun 26, 14[A61K]
2013/0196,428 Cells expressing Th1 characteristics and cytolytic propertiesMar 13, 13Aug 01, 13[C12N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9782463 Method for allogeneic cell therapyFeb 11, 16Oct 10, 17[A61K, C12N]
9695397 Th1 vaccination priming for active immunotherapySep 30, 09Jul 04, 17[A61K, A01N, C12N]
9593308 Device for enhancing immunostimulatory capabilities of T-cellsSep 29, 14Mar 14, 17[A61K, C12N, C07K]
9511127 Method to formulate T-cellsJun 11, 14Dec 06, 16[A61K, C12N]
9352001 Method for stimulating a host immune systemMar 12, 14May 31, 16[A61K, C12N]
9320794 Ablative immunotherapyMar 12, 13Apr 26, 16[A61K, A61B]
9301977 Method for allogeneic cell therapyFeb 05, 14Apr 05, 16[A61K, C12N]
9272001 Ablative immunotherapyJun 01, 11Mar 01, 16[A61K]
9233156 Induction of IL-12 using immunotherapyMay 02, 12Jan 12, 16[A61K]
8883974 Device for enhancing immunostimulatory capabilities of T-cellsMar 31, 11Nov 11, 14[A61K, C12N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
8748580 Device for enhancing immunostimulatory capabilities of T-cellsWithdrawnMar 31, 11Jun 10, 14[A61K, C12N, C07K]
2013/0066,465 Automated device for a biologic drug distributionAbandonedOct 24, 12Mar 14, 13[G06F]
2012/0045,423 Cells expressing TH1 characteristics and cytolytic propertiesAbandonedAug 22, 11Feb 23, 12[A61K, C12N, A61P]
2011/0250,173 Methods and compositions for inhibition of Treg cellsAbandonedApr 12, 11Oct 13, 11[A61K, A61P]
2011/0142,887 Methods and compositions for liquidation of tumorsAbandonedDec 14, 10Jun 16, 11[A61K, C12N, A61B, A61P]
2008/0112,963 Ablative immunotherapyAbandonedNov 07, 07May 15, 08[A61K, A61P]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.